Advertisement

Screening for liver metastases in women with mammary carcinoma: comparison of contrast-enhanced ultrasound and magnetic resonance imaging

Published:November 15, 2010DOI:https://doi.org/10.1016/j.clinimag.2010.09.004

      Abstract

      Objective

      The objective of the present study was to compare conventional B-mode ultrasound (BMU), contrast-enhanced ultrasound (CEUS), and magnetic resonance imaging (MRI) in the detection of liver metastases at the primary staging and follow-up of women with histologically confirmed mammary carcinoma.

      Patients and methods

      Included in the study were 55 women (aged 57.5±11.0 years, range 27–75 years; mean disease duration 57.5 months, range 5–168 months); of these, 17 women were examined as part of primary staging (staging group) and 38 women at follow-up (follow-up group). All patients underwent BMU (Philips HDI 5000), CEUS (Philips HDI 5000; 4.8 ml SonoVue), and MRI (Siemens Avanto 1.5 T) of the liver.

      Results

      In the staging group (n=17), a mass was detected by BMU in 24% (n=4), by CEUS in 29% (n=5), and by MRI in 47% (n=8); masses suspicious for malignancy were identified in 6% of patients with BMU and in 12% each by CEUS and MRI. Malignancy was not confirmed in any case by cytology or surgery. In the follow-up group (n=38), masses were identified by MRI in 53% of patients with suspicion of malignancy in 18%. Malignancy was confirmed in 16% of cases identified at MRI, in 13% of cases identified with CEUS, and in 11% of cases identified with BMU. The Pearson coefficients of correlation were r=.29 (P=.03) for MRI vs. BMU; r=.42 (P=.002) for MRI vs. CEUS; and r=.75 (P≤.001) for BMU vs. CEUS. With respect to malignancy, the Pearson coefficients of correlation were r=.40 (P=.099) for BMU vs. MRI and r=.71 (P=.0009) for CEUS vs. MRI.

      Conclusions

      Beginning in tumor stage III, the use of CEUS and MRI is associated with a significantly greater benefit in the detection of malignant tumors of the liver compared with conventional BMU. BMU appears to be adequate for primary staging and the follow-up of lower tumor stages.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • European School of Oncology (ESO)-MBC Task Force
        Metastatic breast cancer. Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force.
        Breast. 2007; 16: 9-10
        • Ravaioli A
        • Pasini G
        • Polselli A
        • Papi M
        • Tassinari D
        • Arcangeli V
        • Milandri C
        • Amadori D
        • Bravi M
        • Rossi D
        • Fattori PP
        • Pasquini E
        • Panzini I
        Staging of breast cancer: new recommended standard procedure.
        Breast Cancer Res Treat. 2002; 72: 53-60
        • Puglisi F
        • Follador A
        • Minisini AM
        • Cardellino GG
        • Russo S
        • Andreetta C
        • Di Terlizzi S
        • Piga A
        Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.
        Ann Oncol. 2005; 16: 263-266
        • Myers RE
        • Johnston M
        • Pritchard K
        • Levine M
        • Oliver T
        Baseline staging tests in primary breast cancer: a practice guideline.
        CMAJ. 2001; 164: 1439-1444
        • Dietrich CF
        • Kratzer W
        • Strobe D
        • Danse E
        • Fessl R
        • Bunk A
        • Vossas U
        • Hauenstein K
        • Koch W
        • Blank W
        • Oudkerk M
        • Hahn D
        • Greis C
        Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI.
        World J Gastroenterol. 2006; 12: 1699-1705
        • Hohmann J
        • Albrecht T
        • Oldenburg A
        • Skrok J
        • Wolf KJ
        Liver metastases in cancer: detection with contrast-enhanced ultrasonography.
        Abdom Imaging. 2004; 29: 669-681
        • Catala V
        • Nicolau C
        • Vilana R
        • Pages M
        • Bianchi L
        • Sanchez M
        • Bru C
        Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography.
        Eur Radiol. 2007; 17: 1066-1073
        • Dai Y
        • Chen MH
        • Yin SS
        • Yan K
        • Fan ZH
        • Wu W
        • Wang YB
        • Yang W
        Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?.
        Invest Radiol. 2007; 42: 596-603
        • Chami L
        • Lassau N
        • Malka D
        • Ducreux M
        • Bidault S
        • Roche A
        • Elias D
        Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings.
        AJR Am J Roentgenol. 2008; 190: 683-690
        • Clevert DA
        • Jung EM
        • Stock KF
        • Weckbach S
        • Feuerbach S
        • Reiser M
        • Jung F
        Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
        Z Gastroenterol. 2009; 47: 1195-1202
        • Ding H
        • Wang WP
        • Huang BJ
        • Wei RX
        • He NA
        • Qi Q
        • Li CL
        Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue.
        J Ultrasound Med. 2005; 24: 285-297
        • Sandulescu L
        • Saftoiu A
        • Dumitrescu D
        • Ciurea T
        The role of real-time contrast-enhanced and real-time virtual sonography in the assessment of malignant liver lesions.
        J Gastrointestin Liver Dis. 2009; 18: 103-108
        • Okaro AC
        • Durkin DJ
        • Layer GT
        • Kissin MW
        • Karanjia ND
        Hepatic resection for breast cancer metastases.
        Ann R Coll Surg Engl. 2005; 87: 167-170
        • Hoffmann K
        • Franz C
        • Hinz U
        • Schirmacher P
        • Herfarth C
        • Eichbaum M
        • Buchler MW
        • Schemmer P
        Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors.
        Ann Surg Oncol. 2010; 17: 1546-1554
        • Caralt M
        • Bilbao I
        • Cortes J
        • Escartin A
        • Lazaro JL
        • Dopazo C
        • Olsina JJ
        • Balsells J
        • Charco R
        Hepatic resection for liver metastases as part of the “oncosurgical” treatment of metastatic breast cancer.
        Ann Surg Oncol. 2008; 15: 2804-2810
        • Lubrano J
        • Roman H
        • Tarrab S
        • Resch B
        • Marpeau L
        • Scotte M
        Liver resection for breast cancer metastasis: does it improve survival?.
        Surg Today. 2008; 38: 293-299
        • Yedibela S
        • Gohl J
        • Graz V
        • Pfaffenberger MK
        • Merkel S
        • Hohenberger W
        • Meyer T
        Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.
        Ann Surg Oncol. 2005; 12: 778-785
        • Adam R
        • Aloia T
        • Krissat J
        • Bralet MP
        • Paule B
        • Giacchetti S
        • Delvart V
        • Azoulay D
        • Bismuth H
        • Castaing D
        Is liver resection justified for patients with hepatic metastases from breast cancer?.
        Ann Surg. 2006; 244: 897-907
        • Adam R
        • Chiche L
        • Aloia T
        • Elias D
        • Salmon R
        • Rivoire M
        • Jaeck D
        • Saric J
        • Le Treut YP
        • Belghiti J
        • Mantion G
        • Mentha G
        Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model.
        Ann Surg. 2006; 244: 524-535
        • Escobar PF
        • Patrick RJ
        • Rybicki LA
        • Weng DE
        • Crowe JP
        The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups.
        Ann Surg Oncol. 2007; 14: 143-147
        • Couinaud C
        Regulated hepatectomies: excision of the lateral segment of the right liver.
        J Chir (Paris). 1955; 71: 578-603
        • Saverymuttu SH
        • Joseph AE
        • Maxwell JD
        Ultrasound scanning in the detection of hepatic fibrosis and steatosis.
        Br Med J (Clin Res Ed). 1986; 292: 13-15
        • Hamaguchi M
        • Kojima T
        • Itoh Y
        • Harano Y
        • Fujii K
        • Nakajima T
        • Kato T
        • Takeda N
        • Okuda J
        • Ida K
        • Kawahito Y
        • Yoshikawa T
        • Okanoue T
        The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
        Am J Gastroenterol. 2007; 102: 2708-2715
      1. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007;11:37-54, vii.

        • Kratzer W
        • Fritz V
        • Mason RA
        • Haenle MM
        • Kaechele V
        Factors affecting liver size: a sonographic survey of 2080 subjects.
        J Ultrasound Med. 2003; 22: 1155-1161
        • Borchert D
        • Schuler A
        • Muche R
        • Haenle MM
        • Akinli AS
        • Arnold F
        • Kratzer W
        • Pauls S
        Comparison of panorama ultrasonography, conventional B-mode ultrasonography, and computed tomography for measuring liver size.
        Ultraschall Med. 2010; 31: 31-36
        • Bland JM
        • Altman DG
        Measuring agreement in method comparison studies.
        Stat Methods Med Res. 1999; 8: 135-160
        • Abuzallouf S
        • Motawy M
        • Thotathil Z
        Baseline staging of newly diagnosed breast cancer—Kuwait cancer control center experience.
        Med Princ Pract. 2007; 16: 22-24
        • Dillman RO
        • Chico S
        Radiologic tests after a new diagnosis of breast cancer.
        Eff Clin Pract. 2000; 3: 1-6
        • Gerber B
        • Seitz E
        • Muller H
        • Krause A
        • Reimer T
        • Janni W
        • Kundt G
        • Friese K
        A perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread.
        Zentralbl Gynakol. 2004; 126: 275-279
        • Kasem AR
        • Desai A
        • Daniell S
        • Sinha P
        Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer.
        Breast J. 2006; 12: 544-548
        • Bartolotta TV
        • Taibbi A
        • Midiri M
        • Lagalla R
        Focal liver lesions: contrast-enhanced ultrasound.
        Abdom Imaging. 2009; 34: 193-209
        • Janica JR
        • Lebkowska U
        • Ustymowicz A
        • Augustynowicz A
        • Kamocki Z
        • Werel D
        • Polakow J
        • Kedra B
        • Pepinski W
        Contrast-enhanced ultrasonography in diagnosing liver metastases.
        Med Sci Monit. 2007; 13: 111-115
        • Oldenburg A
        • Albrecht T
        Baseline and contrast-enhanced ultrasound of the liver in tumor patients.
        Ultraschall Med. 2008; 29: 488-498
        • Quaia E
        • D'Onofrio M
        • Palumbo A
        • Rossi S
        • Bruni S
        • Cova M
        Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence.
        Eur Radiol. 2006; 16: 1599-1609
        • Larsen LP
        • Rosenkilde M
        • Christensen H
        • Bang N
        • Bolvig L
        • Christiansen T
        • Laurberg S
        The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study.
        Eur J Radiol. 2007; 62: 302-307
        • Gennari A
        • Conte P
        • Rosso R
        • Orlandini C
        • Bruzzi P
        Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.
        Cancer. 2005; 104: 1742-1750
        • Tranquart F
        • Correas JM
        • Ladam Marcus V
        • Manzoni P
        • Vilgrain V
        • Aube C
        • Elmaleh A
        • Chami L
        • Claudon M
        • Cuilleron M
        • Diris B
        • Garibaldi F
        • Lucidarme O
        • Marion D
        • Beziat C
        • Rode A
        • Tasu JP
        • Trillaud H
        • Bleuzen A
        • Le Gouge A
        • Giraudeau B
        • Rusch E
        Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study.
        J Radiol. 2009; 90: 109-122
        • Strobel D
        • Seitz K
        • Blank W
        • Schuler A
        • Dietrich C
        • von Herbay A
        • Friedrich-Rust M
        • Kunze G
        • Becker D
        • Will U
        • Kratzer W
        • Albert FW
        • Pachmann C
        • Dirks K
        • Strunk H
        • Greis C
        • Bernatik T
        Contrast-enhanced ultrasound for the characterization of focal liver lesions—diagnostic accuracy in clinical practice (DEGUM multicenter trial).
        Ultraschall Med. 2008; 29: 499-505
        • Zhou JH
        • Li AH
        • Cao LH
        • Jiang HH
        • Liu LZ
        • Pei XQ
        • Han F
        Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.
        Br J Radiol. 2008; 81: 113-119
        • Della Vigna P
        • Cernigliaro F
        • Monfardini L
        • Gandini S
        • Bellomi M
        Contrast-enhanced ultrasonography in the follow-up of patients with hepatic metastases from breast carcinoma.
        Radiol Med. 2007; 112: 47-55
        • Wang JY
        • Xu BH
        • Tian LJ
        • Wang Y
        Clinical characteristics and potential prognostic factors of breast cancer patients with liver metastases.
        Zhonghua Zhong Liu Za Zhi. 2006; 28: 612-616
        • Romanini L
        • Passamonti M
        • Aiani L
        • Cabassa P
        • Raieli G
        • Montermini I
        • Martegani A
        • Grazioli L
        • Calliada F
        Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience.
        Eur Radiol. 2007; 17: F99-F106